106 results on '"Mano, Roy"'
Search Results
2. PD57-04 MRI-BASED PI-RADS SCORE PREDICTS ISUP UPGRADING AND ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY IN MEN WITH BIOPSY ISUP 1 PROSTATE CANCER
3. PD16-07 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH OUTCOME AND DIFFERS BETWEEN MOLECULAR SUBGROUPS
4. MP41-06 THE ROLE OF MALNUTRITION UNIVERSAL SCREENING TOOL IN PREDICTING OUTCOMES AFTER RADICAL CYSTECTOMY
5. Editorial Comment
6. PD39-10 LONG-TERM SURVIVORS WITH SARCOMATOID RENAL CELL CARCINOMA
7. MP57-16 THE ASSOCIATION BETWEEN MODIFIABLE ANESTHETIC PARAMETERS AND RENAL FUNCTION AFTER NEPHRECTOMY
8. MP21-05 CHANGING PATTERNS OF INTRAOPERATIVE ANALGESIA AND THE EFFECT OF INTRAOPERATIVE OPIOIDS AND ADJUNCT ANALGESICS ON CANCER RECURRENCE AFTER NEPHRECTOMY: A ROLE FOR ONCO-ANESTHESIA?
9. PD62-12 DOES MUTATIONAL BURDEN AFFECT RESPONSE TO CISPLATIN-BASED NEOADJUVANT CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CARCINOMA?
10. MP38-07 URETHRAL MELANOMA – CLINICAL, PATHOLOGICAL AND MOLECULAR CHARACTERISTICS
11. MP25-16 GENOMIC CORRELATES WITH METASTATIC DISSEMINATION IN CYTOREDUCTIVE NEPHRECTOMY
12. MP21-04 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH PROGNOSIS AND VARIES BETWEEN MOLECULAR SUBGROUPS
13. MP42-14 SARCOMATOID FEATURES IN RENAL CELL CARCINOMA: RETHINKING THE STAGE-SURVIVAL PARADIGM
14. MP16-15 COMPREHENSIVE ANALYSIS OF ONCOGENIC EVENTS IN TRANSLOCATION RENAL CELL CARCINOMA
15. MP25-14 AN EVALUATION OF THE ROLE OF TUMOR LOAD IN CYTOREDUCTIVE NEPHRECTOMY
16. MP16-16 IDENTIFYING CLEAR CELL RCC CLONALITY THROUGH ULTRA-DEEP SEQUENCING OF POOLED REGIONAL TUMOR DNA
17. MP38-01 PRIMARY URETHRAL CANCER – TREATMENT PATTERNS AND ASSOCIATED OUTCOMES
18. MP37-09 LATE RELAPSE OF TESTICULAR CANCER – UPDATE OF THE MSKCC EXPERIENCE
19. Clinical Implications of Stent Culture in Patients with Indwelling Ureteral Stents Prior to Ureteroscopy
20. MP23-11 SURGICAL SITE INFECTION AFTER RADICAL CYSTECTOMY – INCIDENCE AND RISK FACTORS
21. PD48-07 RECURRENCE AND PROGRESSION ACCORDING TO STAGE AT RE-TUR IN T1G3 BLADDER CANCER PATIENTS TREATED WITH BCG: NOT AS BAD AS PREVIOUSLY THOUGHT
22. PD07-10 MALIGNANCIES IN MALE BRCA MUTATION CARRIERS – RESULTS FROM A PROSPECTIVELY SCREENED COHORT OF PATIENTS ENROLLED TO A DEDICATED MALE BRCA CLINIC
23. MP74-03 TRANSPLANT KIDNEY RETROGRADE URETERAL STENT PLACEMENT AND EXCHANGE: OVERCOMING THE CHALLENGE
24. MP84-05 HOW LONG SHOULD PATIENTS WAIT BEFORE RESUMING SEXUAL ACTIVITY AFTER BPH SURGERY?
25. PD48-03 RISK FACTORS FOR RESIDUAL DISEASE AT RE-TUR IN T1G3 BLADDER CANCER
26. Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors
27. PD12-12 COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES
28. MP71-14 ANALYSIS OF THE MUTATIONAL LANDSCAPE OF SARCOMATOID CLEAR CELL RENAL CELL CARCINOMA COMPARED TO CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA
29. Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma
30. PD11-12 URINARY TRACT INFECTION AFTER URINARY DIVERSION – DIFFERENT PATTERNS OF OCCURRENCE IN PATIENTS WITH ILEAL CONDUIT AND ORTHOTOPIC NEOBLADDER
31. MP47-09 MOLECULAR CHARACTERIZATION OF SARCOMATOID CLEAR CELL RENAL CELL CARCINOMA
32. MP10-05 CLINICAL OUTCOME OF PATIENTS WITH FIBROSIS/NECROSIS AT POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR ADVANCED GERM CELL TUMORS
33. MP59-02 IMPACT OF URETEROSCOPY PRIOR TO NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA ON ONCOLOGIC OUTCOMES
34. Subcentimeter Pulmonary Nodules are Not Associated with Disease Progression in Patients with Renal Cell Carcinoma
35. Impact of Recurrent Copy Number Alterations and Cancer Gene Mutations on the Predictive Accuracy of Prognostic Models in Clear Cell Renal Cell Carcinoma
36. MP30-18 PATHOLOGIC STAGE T3A SIGNIFICANTLY INCREASES DISEASE RECURRENCE ACROSS ALL TUMOR SIZES IN RENAL CELL CARCINOMA
37. MP23-16 TCEB1 -MUTATED RENAL CELL CARCINOMA: A DISTINCT GENOMIC AND MORPHOLOGIC SUBTYPE
38. MP23-09 INTEGRATED ANALYSIS OF METASTATIC DISEASE IN CLEAR CELL RENAL CELL CARCINOMA: A COLLABORATIVE TCGA ANALYSIS
39. PD17-07 THE CLINICAL SIGNIFICANCE OF INDETERMINATE PULMONARY NODULES IN RENAL CELL CARCINOMA
40. MP23-07 REGIONAL GENETIC VARIABILITY DETECTED WITH RENAL TUMOR BIOPSIES: IMPLICATIONS IN BIOMARKER DEVELOPMENT
41. MP35-19 SORBITOL AS A NOVEL MECHANISM OF HYPOXIA-INDUCIBLE FACTOR (HIF) PATHWAY ACTIVATION IN CLEAR CELL PAPILLARY RENAL CELL CARCINOMA (CCPRCC)
42. MP56-16 THE IMPACT OF RE-TUR ON CLINICAL OUTCOMES IN A LARGE COHORT OF T1G3 PATIENTS TREATED WITH BCG.
43. MP36-02 VALIDATION AND GENOMIC INTERROGATION OF THE MET VARIANT RS11762213 AS A PREDICTOR OF ADVERSE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA
44. PD18-08 CAN MUSCLE−INVASIVE BLADDER CANCER BE PREDICTED IN PATIENTS WITH CLINICAL T1 DISEASE?
45. 1868 PROGNOSTIC VALUE OF BAJORIN CRITERIA FOR CANCER-SPECIFIC SURVIVAL IN PATIENTS WHO HAVE DISEASE RECURRENCE AFTER RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER
46. 440 LOW DOSE ORAL DESMOPRESSIN FOR THE TREATEMNT OF NOCTURNAL ENURESIS IN PATIENTS AFTER RADICAL CYSTECTOMY AND ORTHOTOPIC URINARY DIVERSION – A PROSPECTIVE CASE CONTROL STUDY
47. 1697 PROGNOSTIC FACTORS AND RISK GROUPS IN T1G3 PATIENTS INITIALLY TREATED WITH BCG: RESULTS OF A MULTICENTER RETROSPECTIVE SERIES IN 2530 PATIENTS
48. 1425 URINARY TRACT INFECTION IN PATIENTS WITH AN ORTHOTOPIC NEOBLADDER
49. Resection of Ureteral Orifice During Transurethral Resection of Bladder Tumor: Functional and Oncologic Implications
50. 534 RESECTION OF URETERAL ORIFICES DURING TRANSURETHRAL RESECTION OF BLADDER TUMORS - FUNCTIONAL AND ONCOLOGICAL IMPLICATIONS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.